11β-hydroxysteroid dehydrogenase type 2 in mouse aorta: Localization and influence on response to glucocorticoids

Hypertension

Volumn 42, Issue 4 I, 2003, Pages 580-587

  Christy, Clare ^b   Hadoke, Patrick W F ^a   Paterson, Janice M ^b   Mullins, John J ^b   Seckl, Jonathan R ^b   Walker, Brian R ^b  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Endothelium; Glucocorticoids; Mice; Muscle, smooth, vascular; Vasoconstriction; Vasorelaxation

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ARGININE; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; CORTICOSTERONE; DEHYDROCORTICOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; ISOENZYME; MINERALOCORTICOID RECEPTOR; NITRIC OXIDE; DEXAMETHASONE; HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA;

ANIMAL TISSUE; AORTA; AORTA WALL; ARTICLE; CELL FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG RESPONSE; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE INACTIVATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VASOCONSTRICTION; VASODILATATION; ANIMAL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; AORTA; CORTICOSTERONE; DEXAMETHASONE; ENDOTHELIUM, VASCULAR; GLUCOCORTICOIDS; HYDROXYSTEROID DEHYDROGENASES; ISOENZYMES; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER;

EID: 0141893552     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000088855.06598.5B     Document Type: Article

References (32)

1. Seckl JR, Walker BR. 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific amplifier of glucocorticoid action. Endocrinology, 2001; 142:1371-1376.
2. +-dependent isoform of 11β-hydroxysteroid dehydrogenase: cloning and characterisation of cDNA from sheep kidney. J Biol Chem. 1994;269:25959-25962.
3. Stewart PM, Krozowski ZS. 11-Beta-hydroxysteroid dehydrogenase. Vitam Horm. 1999;57:249-324.
4. Ullian ME. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res. 1999;41:55-64.
5. Mangos G, Walker BR, Kelly JJ, Lawson J, Webb DJ, Whitworth JA. Cortisol inhibits cholinergic dilatation in the human forearm: towards an explanation for glucocorticoid-induced hypertension. Am J hypertens. 2000;13:1155-1160.
6. Johns DG, Dorrance AM, Tramontini NL, Webb RC. Glucocorticoids inhibit tetrahydrobiopterin-dependent endothelial function. Exp Biol Med. 2001;226:27-31.
7. Walker BR, Connacher AA, Webb DJ, Edwards CRW. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin Sci. 1992;83:171-178.
8. Walker BR, Sang KS, Williams BC, Edwards CRW. Direct and indirect effects of carbenoxolone on responses to glucocorticoids and noradrenaline in rat aorta. J Hypertens. 1994;12:33-39.
9. Souness GW, Brem AS, Morris DJ. 11-Beta-hydroxysteroid dehydrogenase antisense affects vascular contractile response and glucocorticoid metabolism. Steroids. 2002;67:195-201.
10. Kotelevtsev YV, Brown RW, Fleming S, Edwards CRW, Seckl JR, Mullins JJ. Hypertension in mice caused by inactivation of 11β-hydroxysteroid dehydrogenase type 2. J Clin Invest. 1999;103:683- 689.
11. Hadoke PWF, Christy C, Kotelevtsev YV, Williams BC, Kenyon CJ, Seckl JR, Mullins JJ, Walker BR. Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11β-hydroxysteroid dehydrogenase. Circulation. 2001;104:2832-2837.
12. Brem AS, Bina RB, King TC, Morris DJ. Localization of 2 11beta-OH steroid dehydrogenase isoforms in aortic endothelial cells. Hypertension. 1998;31:459-462.
13. Hatakeyama H, Inaba S, Miyamori I. 11beta-Hydroxysteroid dehydrogenase in cultured human vascular cells: possible role in the development of hypertension. Hypertensoin. 1999;33:1179-1184.
14. Cai TQ, Wong BM, Mundt SS, Thieringer R, Wright SD, Hermanowski-Vosatka A. Induction of 11beta-hydroxysteroid dehydrogenase type 1 but not type 2 in human aortic smooth muscle cells by inflammatory stimuli. J Steroid Biochem. 2001;77:117-122.
15. Walker BR, Yau JL, Brett LP, Seckl JR, Monder C, Williams BC, Edwards CRW. 11β-Hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology. 1991;129:3305-3312.
16. Brown RW, Chapman KE, Koteletsev Y, Yau JL, Lindsay RS, Brett LP, Leckie CM, Murad P, Lyons V, Mullins JJ, Edwards CRW, Seckl JR, Cloning and production of antisera to human placental 11β-hydroxysteroid dehydrogenase type 2. Biochem J. 1996;313:1007-1017.
17. Smith RE, Li KXZ, Andrews RK, Krozowski ZS. Immunohistochemical and molecular characterization of the rat 11β-hydroxysteroid dehydrogenase type II enzyme. Endocrinology. 1996;138:540-547.
18. Jamieson PM, Chapman KE, Edwards CRW, Seckl JR. 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology. 1995;136:4754-4761.
19. Napolitano A, Voice MW, Edwards CW, Seckl JR, Chapman KE. 11beta-Hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated. J Steroid Biochem Mol Biol. 1998;64:251-260.
20. Funder JW, Pearce PT, Smith R, Campbell J. Vascular type 1 aldosterone binding sites are physiological mineralocorticoid receptors. Endocrinology. 1989;125:2224-2226.
21. Brereton PS, van Driel RR, Suhaimi FFH, Koyama K, Dilley R, Krozowski Z. Light and electron microscopy localization of the 11B- hydroxysteroid dehydrogenase type 1 enzyme in the rat. Endocrinology. 2001;142:1644-1651.
22. Brem AS, Bina RB, Hill N, Alia C, Morris DJ. Effects of licorice derivatives on vascular smooth muscle function. Life Sci. 1997;60: 207-214.
23. Ruschitzka F, Quaschning T, Noll G, deGottardi A, Rossier MF, Enseleit F, Hurlimann D, Luscher TF, Shaw SG. Endothelin 1 type A receptor antagonism prevents vascular dysfunction and hypertension induced by 11β -hydroxysteroid dehyrogenase inhibition. Circulation. 2001;103: 3129-3135.
24. Quaschning T, Ruschitzka F, Shaw S, Luscher TF. Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension. Hypertension. 2001;37:801-805.
25. Kornel L. Colocalization of 11β-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells. Am J hypertens, 1994;7:100-103.
26. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA. 1990;87: 10043-10047.
27. Kornel L, Nelson WA, Manisundaram B, Chigurupati R, Hayashi T. Mechanism of the effects of glucocorticoids and mineralocorticoids on vascular smooth muscle cell contractility. Steroids, 1993;58:580-587.
28. Hayashi T, Nakai T, Miyabo S. Glucocorticoids increase Ca-uptake and [3H] dihydmpyridine binding in A7r% vascular smooth muscle cells. Am J Physiol. 1991;261:C106-C114.
29. Stern N, Palant C, Ozaki L, Tuck ML. Dexamethasone enhances active cation transport in cultured aortic smooth muscle cells. Hypertension. 1994;7:146-150.
30. Brem AS, Bina RB, Metha S, Marshall JJ. Glucocorticoids inhibit the expression of calcium-dependent potassium channels in vascular smooth muscle. Mol Genet Metab. 1999;67:53-57.
31. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol. 1994;105:R11-R17.
32. Best R, Nelson SM, Walker BR. Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11β-hydroxysteroid dehydrogenase in vitro and in vivo. J Endocrinol. 1997;153:41-48.